Large clinical trial to study repurposed drugs to treat COVID-19 symptoms
Using an ACTIV master protocol, the trial will focus on potential interventions for mild-to-moderate illness.
by ·
Using an ACTIV master protocol, the trial will focus on potential interventions for mild-to-moderate illness.
by · Published April 22, 2021
by · Published April 7, 2021
by · Published June 10, 2021